Pallanti S - Search Results

1

Intravenous clomipramine challenge in obsessive-compulsive disorder: predicting response to oral therapy at eight weeks.

Sallee FR, Koran LM, Pallanti S, Carson SW, Sethuraman G. Sallee FR, et al. Among authors: pallanti s. Biol Psychiatry. 1998 Aug 1;44(3):220-7. doi: 10.1016/s0006-3223(97)00373-9. Biol Psychiatry. 1998. PMID: 9693393 Clinical Trial.

2

Intravenous clomipramine for obsessive-compulsive disorder.

Koran LM, Faravelli C, Pallanti S. Koran LM, et al. Among authors: pallanti s. J Clin Psychopharmacol. 1994 Jun;14(3):216-8. J Clin Psychopharmacol. 1994. PMID: 8027426 No abstract available.

3

Smooth-pursuit eye movement and saccadic intrusions in obsessive-compulsive disorder.

Pallanti S, Grecu LM, Gangemi PF, Massi S, Parigi A, Arnetoli G, Quercioli L, Zaccara G. Pallanti S, et al. Biol Psychiatry. 1996 Dec 1;40(11):1164-72. doi: 10.1016/s0006-3223(95)00607-9. Biol Psychiatry. 1996. PMID: 8931920 Clinical Trial.

4

Rapid benefit of intravenous pulse loading of clomipramine in obsessive-compulsive disorder.

Koran LM, Sallee FR, Pallanti S. Koran LM, et al. Among authors: pallanti s. Am J Psychiatry. 1997 Mar;154(3):396-401. doi: 10.1176/ajp.154.3.396. Am J Psychiatry. 1997. PMID: 9054789 Clinical Trial.

5

Pulse loading versus gradual dosing of intravenous clomipramine in obsessive-compulsive disorder.

Koran LM, Pallanti S, Paiva RS, Quercioli L. Koran LM, et al. Among authors: pallanti s. Eur Neuropsychopharmacol. 1998 May;8(2):121-6. doi: 10.1016/s0924-977x(97)00048-5. Eur Neuropsychopharmacol. 1998. PMID: 9619690 Free article. Clinical Trial.

6

Citalopram and sexual side effects of selective serotonin reuptake inhibitors.

Pallanti S, Koran LM. Pallanti S, et al. Am J Psychiatry. 1999 May;156(5):796. doi: 10.1176/ajp.156.5.796. Am J Psychiatry. 1999. PMID: 10327919 No abstract available.

7

Citalopram for treatment-resistant obsessive-compulsive disorder.

Pallanti S, Quercioli L, Paiva RS, Koran LM. Pallanti S, et al. Eur Psychiatry. 1999 Apr;14(2):101-6. doi: 10.1016/s0924-9338(99)80725-1. Eur Psychiatry. 1999. PMID: 10572334 Clinical Trial.

8

Sumatriptan, 5-HT(1D) receptors and obsessive-compulsive disorder.

Koran LM, Pallanti S, Quercioli L. Koran LM, et al. Among authors: pallanti s. Eur Neuropsychopharmacol. 2001 Apr;11(2):169-72. doi: 10.1016/s0924-977x(01)00082-7. Eur Neuropsychopharmacol. 2001. PMID: 11313163 Clinical Trial.

9

Refractory obsessive-compulsive disorder: state-of-the-art treatment.

Hollander E, Bienstock CA, Koran LM, Pallanti S, Marazziti D, Rasmussen SA, Ravizza L, Benkelfat C, Saxena S, Greenberg BD, Sasson Y, Zohar J. Hollander E, et al. Among authors: pallanti s. J Clin Psychiatry. 2002;63 Suppl 6:20-9. J Clin Psychiatry. 2002. PMID: 12027116 Review.

10

Treatment non-response in OCD: methodological issues and operational definitions.

Pallanti S, Hollander E, Bienstock C, Koran L, Leckman J, Marazziti D, Pato M, Stein D, Zohar J; International Treatment Refractory OCD Consortium. Pallanti S, et al. Int J Neuropsychopharmacol. 2002 Jun;5(2):181-91. doi: 10.1017/S1461145702002900. Int J Neuropsychopharmacol. 2002. PMID: 12135542 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

207 results

Search Page